Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma.

Nasopharyngeal carcinoma is highly prevalent in Southern China and Southeast Asia. To unveil the molecular basis of this endemic disease, high-resolution comparative genomic hybridization arrays were used for systematic investigation of genomic abnormalities in 26 nasopharyngeal carcinoma samples. A comprehensive picture of genetic lesions associated with tumorigenesis of nasopharyngeal carcinoma was generated. Consistent chromosomal gains were frequently found on 1q, 3q, 8q, 11q, 12p, and 12q. High incidences of nonrandom losses were identified on chromosomes 3p, 9p, 11q, 14q, and 16q. In addition to previously characterized regions, we have identified several novel minimal regions of gains, including 3q27.3-28, 8q21-24, 11q13.1-13.3, and 12q13, which may harbor candidate nasopharyngeal carcinoma-associated oncogenes. In this study, gain of 11q13.1-13.3 was the most frequently detected chromosomal aberration and a 5.3-Mb amplicon was delineated at this region. Within this 11q13 amplicon, concordant amplification and overexpression of cyclin D1 (CCND1) oncogene was found in nasopharyngeal carcinoma cell lines, xenografts, and primary tumors. Knockdown of cyclin D1 by small interfering RNA in nasopharyngeal carcinoma cell lines led to significant decrease of cell proliferation. The findings suggest that cyclin D1 is a target oncogene at 11q13 in nasopharyngeal carcinoma and its activation plays a significant role in nasopharyngeal carcinoma tumorigenesis.

[1]  L. Zech,et al.  Cytogenetic studies on an epithelioid cell line derived from nasopharyngeal carcinoma. , 2008, Hereditas.

[2]  W. Kuo,et al.  Identification of a Novel Homozygous Deletion Region at 6q23.1 in Medulloblastomas Using High-Resolution Array Comparative Genomic Hybridization Analysis , 2005, Clinical Cancer Research.

[3]  Chenguang Wang,et al.  Minireview: Cyclin D1: normal and abnormal functions. , 2004, Endocrinology.

[4]  Kwok Wai Lo,et al.  Focus on nasopharyngeal carcinoma. , 2004, Cancer cell.

[5]  A. Hui,et al.  Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma , 2003, Molecular carcinogenesis.

[6]  Wen-Lin Kuo,et al.  Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. , 2003, Cancer research.

[7]  H. Kohlhammer,et al.  Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization , 2003, Oncogene.

[8]  K. Lo,et al.  Genetic and epigenetic changes in nasopharyngeal carcinoma. , 2002, Seminars in cancer biology.

[9]  Christian A. Rees,et al.  Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Hui,et al.  Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization. , 2002, International journal of oncology.

[11]  Ajay N. Jain,et al.  Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. , 2002, Cancer research.

[12]  J. Kwong,et al.  High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. , 2001, Cancer research.

[13]  K. To,et al.  High resolution allelotype of microdissected primary nasopharyngeal carcinoma. , 2000, Cancer research.

[14]  W. Kuo,et al.  Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene , 2000, Nature Genetics.

[15]  N. Y. Chung,et al.  Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma , 1999, British Journal of Cancer.

[16]  E. Sausville,et al.  Flavopiridol, a protein kinase inhibitor, down-regulates hypoxic induction of vascular endothelial growth factor expression in human monocytes. , 1999, Cancer research.

[17]  S. Cheung,et al.  Nasopharyngeal carcinoma cell line (C666‐1) consistently harbouring Epstein‐Barr virus , 1999, International journal of cancer.

[18]  A. Hui,et al.  Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisation , 1999, International journal of cancer.

[19]  Peter Lichter,et al.  Amplification and Expression of Cyclin D Genes (CCND1 CCND2 and CCND3) in Human Malignant Gliomas , 1999, Brain pathology.

[20]  A. Hui,et al.  Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. , 1996, Cancer research.

[21]  S. Leung,et al.  Hypermethylation of the p16 gene in nasopharyngeal carcinoma. , 1996, Cancer research.

[22]  D. Huang,et al.  p16 gene alterations in nasopharyngeal carcinoma. , 1995, Cancer research.

[23]  S. Leung,et al.  A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma. , 1994, Cancer research.

[24]  Emma Lees,et al.  Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice , 1994, Nature.

[25]  S. Leung,et al.  Detailed deletion mapping on the short arm of chromosome-3 in nasopharyngeal carcinomas. , 1994, International journal of oncology.

[26]  J. Bartek,et al.  Cyclin D1 expression is regulated by the retinoblastoma protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Weinberg,et al.  Function of a human cyclin gene as an oncogene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Y. F. Poon,et al.  Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx , 1980, International journal of cancer.

[29]  A. Hui,et al.  Characterization of chromosome 3q and 12q amplicons in nasopharyngeal carcinoma cell lines. , 2005, International journal of oncology.